- Home
- ACRV vs PODC Comparison
ACRV vs PODC Comparison
Compare ACRV & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- PODC
- Stock Information
- Founded
- ACRV 2018
- PODC 2013
- Country
- ACRV United States
- PODC United States
- Employees
- ACRV N/A
- PODC N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- PODC
- Sector
- ACRV Health Care
- PODC
- Exchange
- ACRV Nasdaq
- PODC Nasdaq
- Market Cap
- ACRV 42.5M
- PODC 44.1M
- IPO Year
- ACRV 2022
- PODC N/A
- Fundamental
- Price
- ACRV $1.81
- PODC $1.81
- Analyst Decision
- ACRV Strong Buy
- PODC Strong Buy
- Analyst Count
- ACRV 6
- PODC 1
- Target Price
- ACRV $21.80
- PODC $5.00
- AVG Volume (30 Days)
- ACRV 412.6K
- PODC 36.1K
- Earning Date
- ACRV 05-13-2025
- PODC 05-29-2025
- Dividend Yield
- ACRV N/A
- PODC N/A
- EPS Growth
- ACRV N/A
- PODC N/A
- EPS
- ACRV N/A
- PODC N/A
- Revenue
- ACRV N/A
- PODC $49,729,000.00
- Revenue This Year
- ACRV N/A
- PODC $20.67
- Revenue Next Year
- ACRV N/A
- PODC $19.09
- P/E Ratio
- ACRV N/A
- PODC N/A
- Revenue Growth
- ACRV N/A
- PODC 22.98
- 52 Week Low
- ACRV $1.30
- PODC $1.10
- 52 Week High
- ACRV $11.51
- PODC $2.85
- Technical
- Relative Strength Index (RSI)
- ACRV 34.69
- PODC 51.94
- Support Level
- ACRV $1.30
- PODC $1.45
- Resistance Level
- ACRV $2.19
- PODC $1.99
- Average True Range (ATR)
- ACRV 0.32
- PODC 0.22
- MACD
- ACRV 0.10
- PODC 0.04
- Stochastic Oscillator
- ACRV 51.00
- PODC 59.72
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.